New Mounjaro KwikPen Changes 2026: What You Need to Know

On Friday, 6 March 2026, Eli Lilly, manufacturer of the Mounjaro KwikPen, announced an update to its design. This information relates to a physical change to the pen device you use for your weekly weight loss injections.

The weight loss medication itself is not changing. The concentration and the active ingredient, tirzepatide, remain identical to what you have used before.

The change involves the pen’s device hardware and its internal mechanical parts.

These modified pens will arrive in the UK from April 2026. 

This article will explain explain exactly what you will see when you open your next box and help you to understand what these changes mean for your treatment routine.

What Has Changed With Your New Mounjaro Pen?

The main change is how the pen looks and feels internally. 

Eli Lilly has modified the device to reduce the amount of leftover liquid that remains after the fourth and final dose. This helps to show more accurately when your pen is empty and you can dispose of it safely.

The modified pen will replace the old version gradually over several months. The new pen has three specific visual updates.

These are intentional changes designed by the manufacturer to help you track your four doses safely. 

They are structural improvements and do not mean your pen is broken or faulty.

The 3 Main Design Changes

• Plunger Position: The plunger starts further down the cartridge, making it appear that there is less liquid. The pen still holds four doses, and the medication inside has not changed.
• Extended Plunger: A new internal extension piece now sits behind the plunger. This makes the mechanism look significantly longer than previous models.
• End-of-Pen Indicator: The plunger reaches the bottom of the cartridge after the fourth dose. This visual signal confirms the pen is empty and ready for disposal.

What Has Stayed the Same?

Your medication is exactly the same as before. The active ingredient, tirzepatide, remains the same..

Your prescription strength will also stay exactly as it is now. Whether your dose is 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg or 15 mg, the medicine remains the same concentration. 

Only the internal plunger mechanism and the way it moves through the cartridge have changed.

You should still use the pen in the same way as originally instructed by your healthcare provider. Your priming steps, dose dialling and injection methods are still exactly the same as before.

You can continue to follow your usual weekly routine with complete ease and confidence.

What Happened to the “Golden Dose”?

You might have heard of a “golden dose” or a “fifth dose” in the original KwikPen. These terms refer to the extra liquid left in the initial design, that some people used as an unofficial extra dose. 

Using the “golden dose” is not recommended. The remaining liquid is an unmeasured buffer designed for priming the device. This means you can’t guarantee that this leftover liquid will provide an accurate or effective dose of the medication.

Attempting to extract this residual fluid also introduces a high risk of bacterial contamination and infection. This extra medication cannot be accessed without tampering with the device, which will increase the risk of contamination.

This change ensures you follow the official safety rules and use the device exactly as the manufacturer intended. The new, longer plunger reaches much further into the cartridge. This means only a negligible amount of liquid will remain after your fourth dose.

It keeps your weight management treatment safe and predictable by ensuring you take only the approved four doses per pen. 

Using the “leftover” liquid can lead to inaccurate dosing, which might impact your progress.

Why Did Eli Lilly Change the Mounjaro KwikPen?

The main reason for this change is to provide more clarity for patients.

Some people found the remaining liquid in the previous pen confusing, which sometimes raised questions about whether the device had worked correctly.

By reducing leftover liquid, the “empty” state is much clearer for everyone. When you see the plunger hit the end, the process is clearly complete. 

This removes any guesswork or anxiety you might have felt at the end of the month about your doses.

This update brings the UK pen in line with other countries like the USA and Germany. Those markets already use this high-standard device with the modified plunger. 

The goal is a consistent, user-friendly experience that delivers the pen’s four doses accurately every time.

What Does This Mean for You in Practice?

As the dose, strength and usage instructions remain the same, the transition should be straightforward and easy for you to understand. 

The first thing you will notice is that the plunger looks “longer” or more “pushed in” than before. No need to worry if your pen looks different. Both versions are safe and work perfectly for your treatment.

Images provided by Eli Lilly

As this is a rolling change, you do not need a new prescription from your healthcare provider. If you are already prescribed Mounjaro, your existing prescription covers the medicine, regardless of pen design. How you should use the Mounjaro KwikPen remains the same. You should maintain your usual injection day and continue to use the injection sites you prefer.

Continue to check the Instructions for Use (IFU) in the box for visual confirmation. The diagrams in the new leaflet will match the pen you hold in your hand. This will help you feel sure about which version you have and where the plunger should sit. 

If you previously relied on a “golden dose” or a “fifth dose”, be aware that the new pen will have only enough liquid for four doses. Ensure your next month’s supply is ready immediately after your fourth dose to avoid missing any treatment days.

Leftover Mounjaro: Is it Safe to Use? 

No, official advice remains to only take the four prescribed doses from your Mounjaro KwikPen. The device guarantees four 0.6 ml injections only. 

Any liquid left after is “residual waste” and you should not use it.

The manufacturer, Eli Lilly, can’t promise the accuracy of the dose of any extra liquid left in the tube. Using it can lead to receiving too little medication, which might not be effective for your weight loss journey. 

Taking the pen apart to access any remaining medication can also be potentially unsafe.

The modified pen makes it much easier for you to stay safe when using Mounjaro by removing the temptation to save leftover fluid. It aligns your pen with the official usage guidance in the patient information leaflet and Instructions for Use (IFU). 

Stick to the four-dose schedule provided by your healthcare professional to ensure the medicine works effectively. Your safety is the priority, and using the pen as designed is the best way to protect it. 

Where and When to Get Advice

If you receive a new pen and feel unsure about how it looks, talk to your healthcare provider. They are there to support you through every part of your treatment. 

Don’t hesitate to reach out if you feel confused by the transition or the new packaging.

Key Takeaways

• Updated Design: The pen has a longer plunger and new internal parts to reduce leftover waste.
• Same Medicine: Your tirzepatide dose, concentration and formula have not changed at all.
• Gradual Rollout: You might receive either the original design pen or new design pen starting from April 2026.
• No More 5th Dose: The new design makes it clear the pen is empty after your four weekly doses.
• Same Routine: Your weekly injection day, priming steps and storage rules remain exactly the same.

References

How to Use the Mounjaro (tirzepatide) KwikPen, Eli Lilly and Company (2024) (Accessed March 2026)